Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H. Barouch(Beth Israel Deaconess Medical Center), Ludo Lavreys(Janssen (Belgium)), Glenda Gray(South African Medical Research Council), Caroline Borremans(Janssen (Belgium)), Lauren Peter(Beth Israel Deaconess Medical Center), Kundai Chinyenze(International AIDS Vaccine Initiative), Juliet Mpendo(Uganda Virus Research Institute), Bette Korber(Los Alamos National Laboratory), Thomas Campbell(University of Colorado Anschutz Medical Campus), Etienne Karita(Rwanda Biomedical Center), Lorenz Scheppler(Janssen (Belgium)), Erica N. Borducchi(Beth Israel Deaconess Medical Center), Georgia D. Tomaras(National Institutes of Health), Jerald Sadoff(University of Maryland, Baltimore), Kathryn E. Stephenson(Beth Israel Deaconess Medical Center), Nelson L. Michael(Walter Reed Army Institute of Research), Roland Zahn(Johnson & Johnson (Israel)), Stephan Bart(Optimal Solutions (United States)), Edith Swann(National Institutes of Health), Nicole Frahm(Fred Hutch Cancer Center), Frances Priddy(International AIDS Vaccine Initiative), Jessica Vreugdenhil(Janssen (Netherlands)), Fatima Laher(University of the Witwatersrand), Punnee Pitisuttithum(Mahidol University), Mo Weijtens(Janssen (Netherlands)), Galit Alter(Ragon Institute of MGH, MIT and Harvard), David Jetton(Beth Israel Deaconess Medical Center), Daniëlle van Manen(Janssen (Netherlands)), Abishek Chandrashekar(Beth Israel Deaconess Medical Center), Hannah Kibuuka(Makerere University Walter Reed Project), Daniel J Stieh(Janssen (Netherlands)), Sorachai Nitayapan(Armed Forces Research Institute of Medical Science), Erica Lazarus(Norwegian Womens Public Health Association), Merlin L. Robb(University of Maryland, Baltimore), Raphaele Roten(Janssen (Belgium)), Gregg Lucksinger, Katleen Callewaert(Janssen (Belgium)), Frank Wegmann(Janssen (Netherlands)), M. Juliana McElrath(Fred Hutch Cancer Center), Lindsey R. Baden(Brigham and Women's Hospital), Joseph P. Nkolola(Beth Israel Deaconess Medical Center), Julia Hütter(National Institutes of Health), Wenjun Li(Xinjiang Institute of Ecology and Geography), Jennifer Johnson(Northwestern University), Robert Feldman, Frank Tomaka(Janssen (United States)), David C. Montefiori(Duke University), Karin Feddes-de Boer(Janssen (Netherlands)), Nigel Garrett(Centre for the AIDS Programme of Research in South Africa)
Cited by 342
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k